Mounjaro®
Starting from £179.99/mo
Start journey Learn moreEach Mounjaro 15mg KwikPen contains four weekly doses, and each dose is delivered with a single click of the pen's injection button. So across the full pen, you press four times in total, once per week over four weeks. That click mechanism is one of the things patients ask our prescribers about most weeks — usually because they want to know whether a partial pen is safe to use or whether they've administered the dose correctly. The rest of this page explains exactly how the pen works, what those clicks tell you, and what to do if anything seems off. Because Mounjaro is a prescription-only medicine, how you use it should always be guided by your prescriber and the Patient Information Leaflet supplied with your pen.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When a 15mg pen arrives, the dose counter displays the number 4. That number tells you four complete doses remain. Before you do anything else, check that figure. If it reads anything other than 4 on a brand-new, sealed pen, do not use it and contact your pharmacy straight away.
Hold the pen up to the light and look through the window at the side. The solution should appear clear and colourless or very faintly yellow. Any cloudiness, visible particles or discolouration means you should not inject it. The pen should also have been refrigerated during transit; room-temperature storage is permitted for a limited period, but the exact window is stated in the Patient Information Leaflet, and your prescriber is the right person to ask if you have any doubts about a pen that was left out.
Once you're satisfied, attach a new needle, prime if your Patient Information Leaflet advises it, and choose your injection site. The abdomen, thigh and upper arm are all suitable; rotating the site each week reduces skin irritation over time. The approach to injection technique is consistent across all pen strengths, so if you started treatment at a lower dose you'll already know the process.
Press the pen firmly against the skin, then push the injection button with your thumb until you hear and feel a single click. Hold the pen in place for around ten seconds (the leaflet gives the precise timing) then remove it. That single action delivers the full 15mg dose. There is no partial dosing, no second click required and no way to accidentally deliver more than one dose at a time, because the mechanism physically resets only when the pen is placed against skin again for the next injection.
After the click, the dose counter decreases by one. Week one: the display moves from 4 to 3. Week two: 3 to 2. And so on. If the counter has not moved after what felt like a complete injection, consult your Patient Information Leaflet and contact your prescriber before attempting another injection. Do not inject a second time to compensate.
For context on how the click counts differ at earlier stages of treatment, the 10mg pen follows the same four-click structure but at a lower dose per activation, the mechanism is identical, the strength differs. If you're still working through the earlier titration stages, it's also worth understanding how the 5mg pen's clicks are counted and what to expect from each one.
The counter is your record. After each injection: 4 becomes 3, 3 becomes 2, 2 becomes 1. When the display reaches 0 and the button is grey and locked, the pen is finished. Do not try to extract further medication; none remains.
Dispose of the used pen in an approved sharps container immediately after use, placing a needle directly in household waste is unsafe and, in most UK areas, against local disposal guidelines. If you're unsure about timing your next pen, or you've accidentally missed a dose, speak to your prescriber rather than doubling up. The general guidance is that a missed dose can be taken up to four days late, but your prescriber and the leaflet should confirm what's right for your situation.
A question our prescribers hear most weeks at this dose is whether the pen can be stored out of the fridge between injections. The short answer is that it can (for a defined period) but the exact duration is specified in the leaflet and varies slightly by manufacturing lot; always check rather than guess. If you're travelling with your treatment, the frequently asked questions page covers storage and travel practicalities in more detail.
Mounjaro's licensed schedule begins at 2.5mg, a dose designed to let your body adjust rather than to produce significant weight loss in the first weeks. Titration moves through 5mg, 7.5mg, 10mg and 12.5mg before reaching 15mg, typically over several months. The 7.5mg pen, for example, is often where patients first notice appetite changes settling into a comfortable rhythm.
At 15mg (the highest available strength) the SURMOUNT-1 trial, published in the New England Journal of Medicine, reported an average body-weight reduction of around 20–21% over 72 weeks in adults with obesity. That figure comes from a controlled trial setting; your own results will depend on your starting weight, your diet and activity patterns, and how consistently you use the treatment. For a broader look at the evidence behind the medicine, the NICE technology appraisal TA1026 reviews the clinical data in detail.
Reaching 15mg requires a clinical decision at each step. No prescriber should jump a patient straight to the highest dose, and titration is not something to self-manage. If weight loss stalls or side effects are difficult at any point, that's a conversation for your prescriber. The page on weight plateaus at 15mg addresses what can happen if progress slows even at the maximum dose, and what options exist. For anything to do with your specific treatment plan, the NHS tirzepatide patient information is a solid starting reference alongside your own prescriber's advice.
If you're considering treatment but haven't yet spoken to a clinician, a free consultation with our prescribers is the right first step. Eligibility is assessed individually, your BMI, health history and current medicines all factor in.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.